ACE and hepatocellular carcinoma: Liebman et al. [40] and Koike Y et al. [41] demonstrated that DCP can be used as a very specific diagnostic and prognostic marker in HCC patients in two multicentre and prospective studies involving 76 and 227 patients, respectively.